Current Management of Erectile Dysfunction

Erectile dysfunction (ED) is a prevalent male sexual dysfunction that can be categorized into organic and psychological forms. The organic type is further subdivided into neurogenic, vasogenic, drug-induced, and endocrine subtypes, among others. Risk factors for ED include smoking, obesity, diabetes, cardiovascular disease, and various psychological influences. Treatment strategies for managing the symptoms encompass lifestyle modifications, pharmacotherapy, physical therapy, stem cell therapy, and surgical interventions. Pharmacological options consist of phosphodiesterase inhibitors, testosterone, and α-adrenoceptor antagonists, while physical modalities include vacuum erection devices, prostaglandin E1 injection, and low-intensity extracorporeal shock wave therapy (LI-ESWT). Surgical procedures such as penile prosthesis implantation, are typically reserved for patients unsuited to non-surgical approaches or those experiencing adverse effects or unresponsiveness to medical therapy. This review elaborates on key aspects of ED, investigates diverse pathological mechanisms associated with the disorder, and outlines current treatment modalities.

Authors

Publication Details

Journal
International Journal of Drug Discovery and Pharmacology
Published
2025-08-08
DOI
https://doi.org/10.53941/ijddp.2025.100013
Primary Topic
Sexual function and dysfunction studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current Management of Erectile Dysfunction

Siqi Wang
International Journal of Drug Discovery and Pharmacology
Sexual function and dysfunction studies
article

Current Management of Erectile Dysfunction

Siqi Wang
article en

Abstract

Erectile dysfunction (ED) is a prevalent male sexual dysfunction that can be categorized into organic and psychological forms. The organic type is further subdivided into neurogenic, vasogenic, drug-induced, and endocrine subtypes, among others. Risk factors for ED include smoking, obesity, diabetes, cardiovascular disease, and various psychological influences. Treatment strategies for managing the symptoms encompass lifestyle modifications, pharmacotherapy, physical therapy, stem cell therapy, and surgical interventions. Pharmacological options consist of phosphodiesterase inhibitors, testosterone, and α-adrenoceptor antagonists, while physical modalities include vacuum erection devices, prostaglandin E1 injection, and low-intensity extracorporeal shock wave therapy (LI-ESWT). Surgical procedures such as penile prosthesis implantation, are typically reserved for patients unsuited to non-surgical approaches or those experiencing adverse effects or unresponsiveness to medical therapy. This review elaborates on key aspects of ED, investigates diverse pathological mechanisms associated with the disorder, and outlines current treatment modalities.

International Journal of Drug Discovery and Pharmacology
National Science Foundation, National Natural Science Foundation of China, Peking University
Good health and well-being
Openalex Percentile: Top 75%
Sexual function and dysfunction studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Current Management of Erectile Dysfunction — Siqi Wang · International Journal of Drug Discovery and Pharmacology (2025) | TGRS Research Map | TGRS